| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 2,506,000 | 2,808,000 | 2,970,000 | 3,870,000 | | Cost of Revenue | 2,119,000 | 2,295,000 | 2,323,000 | 3,215,000 | | | Gross Profit | 387,000 | 513,000 | 647,000 | 655,000 | | | Operating Expenses | | Research Development | 101,000 | 130,000 | 108,000 | 91,000 | | Selling General and Administrative | 309,000 | 300,000 | 376,000 | 382,000 | | Non Recurring |
-
| (3,000) | 58,000 | 358,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (23,000) | 86,000 | 105,000 | (176,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 56,000 | (22,000) | 198,000 | (25,000) | | Earnings Before Interest And Taxes | 58,000 | 78,000 | 320,000 | (193,000) | | Interest Expense | 56,000 | 57,000 | 93,000 | 112,000 | | Income Before Tax | 2,000 | 21,000 | 227,000 | (305,000) | | Income Tax Expense | 30,000 | 9,000 | (7,000) | 38,000 | | Minority Interest | (7,000) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (35,000) | 12,000 | 234,000 | (343,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items | 23,000 |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,000) | 12,000 | 234,000 | (343,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,000) | $12,000 | $234,000 | ($343,000) |
|
0.28% Nasdaq 
Income Statement
